Patients with poor response to antipsychotics have a more severe pattern of frontal atrophy: a voxel-based morphometry study of treatment resistance in schizophrenia
Patients with poor response to antipsychotics have a more severe pattern of frontal atrophy: a voxel-based morphometry study of treatment resistance in schizophrenia(331 views) Quarantelli M, Palladino O, Prinster A, Schiavone V, Carotenuto B, Brunetti A, Marsili A, Casiello M, Muscettola G, Salvatore M, De Bartolomeis A
Biomed Res Int (ISSN: 2314-6133, 2314-6141, 2314-6141electronic), 2014; 2014: 325052-325052.
Keywords: Adult, Antipsychotic Agents, Pharmacology, Therapeutic Use, Atrophy, Demography, Frontal Lobe, Drug Effects, Pathology, Gray Matter, Humans, Organ Size, Schizophrenia, Drug Therapy, Treatment Outcome, Anticonvulsive Agent, Antiparkinson Agent, Aripiprazole, Benzodiazepine Derivative, Bromperidol, Carbamazepine, Chlorpromazine, Clotiapine, Clozapine, Haloperidol, Olanzapine, Paliperidone, Perphenazine, Quetiapine, Risperidone, Serotonin Uptake Inhibitor, Neuroleptic Agent, Article, Brain Atrophy, Brain Size, Controlled Study, Frontal Gyrus, Major Clinical Study, Middle Frontal Gyrus, Nuclear Magnetic Resonance Scanner, Post Hoc Analysis, Postcentral Gyrus, Randomized Controlled Trial, Superior Frontal Gyrus, Temporal Cortex, Voxel Based Morphometry,
Affiliations: *** IBB - CNR ***
Biostructure and Bioimaging Institute, National Research Council, Via T. De Amicis 95, 80145 Naples, Italy.
Section of Psychiatry, Department of Neuroscience and Reproductive and Odontostomatological Sciences, University "Federico II", 80131 Naples, Italy.
IDC Hermitage Capodimonte Spa, 80145 Naples, Italy.
Department of Advanced Biomedical Sciences, University "Federico II", 80131 Naples, Italy.
References: Elkis, H., Treatment-resistant schizophrenia (2007) Psychiatric Clinics of North America, 30 (3), pp. 511-53
Conley, R.R., Kelly, D.L., Management of treatment resistance in schizophrenia (2001) Biological Psychiatry, 50 (11), pp. 898-911
Essock, S.M., Hargreaves, W.A., Covell, N.H., Goethe, J., Clozapine's effectiveness for patients in state hospitals: Results from a randomized trial (1996) Psychopharmacology Bulletin, 32 (4), pp. 683-697
Brenner, H.D., Dencker, S.J., Goldstein, M.J., Defining treatment refractoriness in schizophrenia (1990) Schizophrenia Bulletin, 16 (4), pp. 551-561
Conley, R.R., Buchanan, R.W., Evaluation of treatmentresistant schizophrenia (1997) Schizophrenia Bulletin, 23 (4), pp. 663-674
Kennedy, J.L., Altar, C.A., Taylor, D.L., Degtiar, I., Hornberger, J.C., The social and economic burden of treatmentresistant schizophrenia: A systematic literature review (2014) International Clinical Psychopharmacology, 29 (2), pp. 63-76
De Bartolomeis, A., Balletta, R., Giordano, S., Buonaguro, E.F., Latte, G., Iasevoli, F., Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: Correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses (2013) Psychiatry Research, 210 (2), pp. 387-395
Kane, J., Honigfeld, G., Singer, J., Meltzer, H., Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine (1988) Archives of General Psychiatry, 45 (9), pp. 789-796
Lieberman, J., Jody, D., Geisler, S., Time course and biologic correlates of treatment response in first-episode schizophrenia (1993) Archives of General Psychiatry, 50 (5), pp. 369-376
Meltzer, H.Y., Rabinowitz, J., Lee, M.A., Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance (1997) The American Journal of Psychiatry, 154 (4), pp. 475-482
Johnstone, E.C., Owens, D.G.C., Bydder, G.M., Colter, N., Crow, T.J., Frith, C.D., The spectrum of structural brain changes in schizophrenia: Age of onset as a predictor of cognitive and clinical impairments and their cerebral correlates (1989) Psychological Medicine, 19 (1), pp. 91-103
Kolakowska, T., Williams, A.O., Ardern, M., Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction (1985) British Journal of Psychiatry, 146, pp. 229-239
Friedman, L., Knutson, L., Shurell, M., Meltzer, H.Y., Prefrontal sulcal prominence is inversely related to response to clozapine in schizophrenia (1991) Biological Psychiatry, 29 (9), pp. 865-877
Honer, W.G., Smith, G.N., Lapointe, J.S., Macewan, G.W., Kopala, L., Altman, S., Regional cortical anatomy and clozapine response in refractory schizophrenia (1995) Neuropsychopharmacology, 13 (1), pp. 85-87
Lawrie, S.M., Ingle, G.T., Santosh, C.G., Magnetic resonance imaging and single photon emission tomography in treatment-responsive and treatment-resistant schizophrenia (1995) British Journal of Psychiatry, 167, pp. 202-210
Lawrie, S.M., Abukmeil, S.S., Chiswick, A., Egan, V., Santosh, C.G., Best, J.J.K., Qualitative cerebral morphology in schizophrenia: A magnetic resonance imaging study and systematic literature review (1997) Schizophrenia Research, 25 (2), pp. 155-166
Konicki, P.E., Kwon, K.Y., Steele, V., Prefrontal cortical sulcal widening associated with poor treatment response to clozapine (2001) Schizophrenia Research, 48 (2-3), pp. 173-176
Savas, H.A., Unal, B., Erbagci, H., Hippocampal volume in schizophrenia and its relationship with risperidone treatment: A stereological study (2002) Neuropsychobiology, 46 (2), pp. 61-66
Molina, V., Reig, S., Sanz, J., Differential clinical, structural and P300 parameters in schizophrenia patients resistant to conventional neuroleptics (2008) Progress in Neuro-Psychopharmacology & Biological Psychiatry, 32 (1), pp. 257-266
Arango, C., Breier, A., McMahon, R., Carpenter, W.T., Jr., Buchanan, R.W., The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes (2003) American Journal of Psychiatry, 160 (8), pp. 1421-1427
Zipursky, R.B., Zhang-Wong, J., Lambe, E.K., Bean, G., Beiser, M., MRI correlates of treatment response in first episode psychosis (1998) Schizophrenia Research, 30 (1), pp. 81-90
Gardner, D.M., Murphy, A.L., O'Donnell, H., Centorrino, F., Baldessarini, R.J., International consensus study of antipsychotic dosing (2010) The American Journal of Psychiatry, 167 (6), pp. 686-693
Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI singlesubject brain (2002) NeuroImage, 15 (1), pp. 273-289
Roncone, R., Ventura, J., Impallomeni, M., Reliability of an italian standardized and expanded brief psychiatric rating scale (BPRS 4.0) in raters with high vs. Low clinical experience (1999) Acta Psychiatrica Scandinavica, 100 (3), pp. 229-236
Kalla, O., Aaltonen, J., Wahl-Ström, J., Lehtinen, V., García Cabeza, I., Chávez De González, M., Duration of untreated psychosis and its correlates first-episode psychosis in Finland and Spain (2002) Acta Psychiatrica Scandinavica, 106 (4), pp. 265-275
NICE, (2002) Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care, , National Institute for Health and Clinical Excellence, London, UK
NICE, (2003) Schizophrenia
Full National Clinical Guidelines on Core Interventions in Primary and Secondary Care, , National Institute for Health and Clinical Excellence, London, UK
Velligan, D.I., Lam, Y.F., Glahn, D.C., Defining and assessing adherence to oral antipsychotics: A review of the literature (2006) Schizophrenia Bulletin, 32 (4), pp. 724-742
Ventura, J., Nuechterlein, K.H., Subotnik, K.L., Gutkind, D., Gilbert, E.A., Symptom dimensions in recent-onset schizophrenia and mania: A principal components analysis of the 24-item Brief Psychiatric Rating Scale (2000) Psychiatry Research, 97 (2-3), pp. 129-135
Harris, M.G., Henry, L.P., Harrigan, S.M., Therelationship between duration of untreated psychosis and outcome: An eightyear prospective study (2005) Schizophrenia Research, 79 (1), pp. 85-93
Lyne, J.P., Kinsella, A., O'donoghue, B., Can we combine symptom scales for collaborative research projects? (2012) Journal of Psychiatric Research, 46 (2), pp. 233-238
Welham, J., Stedman, T., Clair, A., Choosing negative symptom instruments: Issues of representation and redundancy (1999) Psychiatry Research, 87 (1), pp. 47-56
Eckert, S.L., Diamond, P.M., Miller, A.L., Velligan, D.I., Funderburg, L.G., True, J.E., A comparison of instrument sensitivity to negative symptom change (1996) Psychiatry Research, 63 (1), pp. 67-75
Good, C.D., Johnsrude, I.S., Ashburner, J., Henson, R.N.A., Friston, K.J., Frackowiak, R.S.J., A voxel-based morphometric study of ageing in 465 normal adult human brains (2001) NeuroImage, 14 (1), pp. 21-36
Bullmore, E.T., Suckling, J., Overmeyer, S., Rabe-Hesketh, S., Taylor, E., Brammer, M.J., Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain (1999) IEEE Transactions on Medical Imaging, 18 (1), pp. 32-42
Suckling, J., Bullmore, E., Permutation tests for factorially designed neuroimaging experiments (2004) Human Brain Mapping, 22 (3), pp. 193-205
Pantelis, C., Velakoulis, D., McGorry, P.D., Neuroanatomical abnormalities before and after onset of psychosis: A crosssectional and longitudinal MRI comparison (2003) The Lancet, 361 (9354), pp. 281-288
Turetsky, B., Cowell, P.E., Gur, R.C., Grossman, I., Shtasel, D.L., Gur, R.E., Frontal and temporal lobe brain volumes in schizophrenia: Relationship to symptoms and clinical subtype (1995) Archives of General Psychiatry, 52 (12), pp. 1061-1070
Okugawa, G., Sedvall, G.C., Agartz, I., Reduced grey and white matter volumes in the temporal lobe of male patients with chronic schizophrenia (2002) European Archives of Psychiatry and Clinical Neuroscience, 252 (3), pp. 120-123
Glahn, D.C., Laird, A.R., Ellison-Wright, I., Metaanalysis of gray matter anomalies in schizophrenia: Application of anatomic likelihood estimation and network analysis (2008) Biological Psychiatry, 64 (9), pp. 774-781
Molina, V., Martín, C., Ballesteros, A., De Herrera, A.G.S., Hernández-Tamames, J.A., Optimized voxel brain morphometry: Association between brain volumes and the response to atypical antipsychotics (2011) European Archives of Psychiatry and Clinical Neuroscience, 261 (6), pp. 407-416
Stip, E., Mancini-Marïe, A., Letourneau, G., Increased grey matter densities in schizophrenia patients with negative symptoms after treatment with quetiapine: A voxel-based morphometry study (2009) International Clinical Psychopharmacology, 24 (1), pp. 34-41
Tomelleri, L., Jogia, J., Perlini, C., Brain structural changes associated with chronicity and antipsychotic treatment in schizophrenia (2009) European Neuropsychopharmacology, 19 (12), pp. 835-840
Van Haren, N.E.M., Hulshoff Pol, H.E., Schnack, H.G., Focal gray matter changes in schizophrenia across the course of the illness: A 5-year follow-up study (2007) Neuropsychopharmacology, 32 (10), pp. 2057-2066
Molina, V., Hernández, J.A., Sanz, J., Subcortical and cortical gray matter differences between Kraepelinian and non-Kraepelinian schizophrenia patients identified using voxelbasedmorphometry (2010) Psychiatry Research, 184 (1), pp. 16-22
Knoll, J.L., IV, Garver, D.L., Ramberg, J.E., Kingsbury, S.J., Croissant, D., McDermott, B., Heterogeneity of the psychoses: Is there a neurodegenerative psychosis? (1998) Schizophrenia Bulletin, 24 (3), pp. 365-379
Nenadic, I., Sauer, H., Gaser, C., Distinct pattern of brain structural deficits in subsyndromes of schizophrenia delineated by psychopathology (2010) NeuroImage, 49 (2), pp. 1153-1160
Bakken, T.E., Bloss, C.S., Roddey, J.C., Association of genetic variants on 15q12 with cortical thickness and cognition in schizophrenia (2011) Archives of General Psychiatry, 68 (8), pp. 781-790
Oertel-Knöchel, V., Knöchel, C., Rotarska-Jagiela, A., Association between psychotic symptoms and cortical thickness reduction across the schizophrenia spectrum (2013) Cerebral Cortex, 23 (1), pp. 61-70
Leung, M., Cheung, C., Yu, K., Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment: Anatomical likelihood estimation meta-analyses with sample size weighting (2011) Schizophrenia Bulletin, 37 (1), pp. 199-211
Smieskova, R., Fusar-Poli, P., Allen, P., The effects of antipsychotics on the brain: What have we learnt fromstructural imaging of schizophrenia?-A systematic review (2009) Current Pharmaceutical Design, 15 (22), pp. 2535-2549
Navari, S., Dazzan, P., Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings (2009) Psychological Medicine, 39 (11), pp. 1763-1777
VanHaren, N.E.M., Schnack, H.G., Cahn, W., Changes in cortical thickness during the course of illness in schizophrenia (2011) Archives of General Psychiatry, 68 (9), pp. 871-880
Ho, B., Andreasen, N.C., Ziebell, S., Pierson, R., Magnotta, V., Long-term antipsychotic treatment and brain volumes: A longitudinal study of first-episode schizophrenia (2011) Archives of General Psychiatry, 68 (2), pp. 128-137
Andreasen, N.C., Nopoulos, P., Magnotta, V., Pierson, R., Ziebell, S., Ho, B., Progressive brain change in schizophrenia: A prospective longitudinal study of first-episode schizophrenia (2011) Biological Psychiatry, 70 (7), pp. 672-679
Poser, W., Poser, S., Roscher, D., Argyrakis, A., Do benzodiazepines cause cerebral atrophy? (1983) The Lancet, 1 (8326), p. 715
Liu, R.S.N., Lemieux, L., Bell, G.S., Cerebral damage in epilepsy: A population-based longitudinal quantitative MRI study (2005) Epilepsia, 46 (9), pp. 1482-1494
Robinson, D.G., Woerner, M.G., Alvir, J.M.J., Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder (1999) The American Journal of Psychiatry, 156 (4), pp. 544-549
Peuskens, J., The evolving definition of treatment resistance (1999) Journal of Clinical Psychiatry, 60 (12), pp. 4-8
Patients with poor response to antipsychotics have a more severe pattern of frontal atrophy: a voxel-based morphometry study of treatment resistance in schizophrenia
Patients with poor response to antipsychotics have a more severe pattern of frontal atrophy: a voxel-based morphometry study of treatment resistance in schizophrenia
Patients with poor response to antipsychotics have a more severe pattern of frontal atrophy: a voxel-based morphometry study of treatment resistance in schizophrenia
Kim YH, Shin SW, Pellicano R, Fagoonee S, Choi IJ, Kim YI, Park B, Choi JM, Kim SG, Choi J, Park JY, Oh S, Yang HJ, Lim JH, Im JP, Kim JS, Jung HC, Ponzetto A, Figura N, Malfertheiner P, Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH, Bae SE, Choi KD, Choe J, Kim SO, Na HK, Choi JY, Ahn JY, Jung KW, Lee J, Kim DH, Chang HS, Song HJ, Lee GH, Jung HY, Seta T, Takahashi Y, Noguchi Y, Shikata S, Sakai T, Sakai K, Yamashita Y, Nakayama T, Leja M, Park JY, Murillo R, Liepniece-karele I, Isajevs S, Kikuste I, Rudzite D, Krike P, Parshutin S, Polaka I, Kirsners A, Santare D, Folkmanis V, Daugule I, Plummer M, Herrero R, Tsukamoto T, Nakagawa M, Kiriyama Y, Toyoda T, Cao X, Corral JE, Mera R, Dye CW, Morgan DR, Lee YC, Lin JT, Garcia Martin R, Matia Cubillo A, Lee SH, Park JM, Han YM, Ko WJ, Hahm KB, Leontiadis GI, Ford AC, Ichinose M, Sugano K, Jeong M, Park JM, Han YM, Park KY, Lee DH, Yoo JH, Cho JY, Hahm KB, Bang CS, Baik GH, Shin IS, Kim JB, Suk KT, Yoon JH, Kim YS, Kim DJ * Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer(295 views) N Engl J Med (ISSN: 0028-4793, 0028-4793linking, 1533-4406electronic), 2015 Jun; 30642104201566393291: 749-756. Impact Factor:59.558 ViewExport to BibTeXExport to EndNote
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(495 views) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 ViewExport to BibTeXExport to EndNote